NCT05492656

Brief Summary

The endoscopist performances in the optical diagnosis (OD) of colonic polyps with the available technologies vary widely across centers and across endoscopists. The OD process is strictly related to the operator training and expertise. Most of the available studies in optical characterization have been carried out by expert endoscopist in tertiary high volume centers, and weren't replied on large unselected populations. For these reasons, at the moment the optical characterization of polypoid lesions can't replace, in the everyday clinical practice, the histopathological evaluation of resected polyps. Artificial intelligence (AI)-based systems have the potential to make optical characterization process of colonic polyps easier and more reliable, thus supporting the endoscopist in the application of leave-in-situ and of resect-and-discard strategies. The implementation of such strategies would lead to a significant economic saving and a decrease of risks and complications related to unnecessary polypectomy. GI-Genius System (Medtronic Inc, Minneaopolis, USA) is a CNN-based algorithm allowing an automatic OD of colonic polyps. This system does not require dedicated light setting for polyp evaluation as it works with white light high definition images, which are the actual standard in every endoscopic unit. During colonoscopy, when a polyp is framed within the screen, a green detection box surrounds the polyp and the system automatically provides (whenever possible) the optical diagnosis labeling the polyp as "adenoma or non-adenoma". When the automatic polyp charaterization is unfeasible the label "no prediction" appears. Nowadays only few data about the feasibility and performances of this system in clinical practice are available. In addition published studies are mostly focused on technical rather thann clinical issues. The present prospective observational trial is primarily aimed at evaluating the diagnostic accuracy of optical characterization of colonic polyps \<= 1 cm using GI-Genius System in daily clinical practice, having histopathology examination as reference standard.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 5, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

August 5, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 8, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 5, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2022

Completed
Last Updated

March 26, 2024

Status Verified

March 1, 2024

Enrollment Period

3 months

First QC Date

August 5, 2022

Last Update Submit

March 24, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy of CADx in evaluating small colonic polyps

    Numer of correctly characterized polyps using AI/total number of detected polyps

    Entire study duration (3 months)

Secondary Outcomes (5)

  • Feasibility of CADx in evaluating small colonic polyps

    Entire study duration (3 months)

  • Sensitivity

    Entire study duration (3 months)

  • specificity

    Entire study duration (3 months)

  • Positive predictive value

    Entire study duration (3 months)

  • Negative predictive value

    Entire study duration (3 months)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive adults (18-85 years) outpatients referred for colonoscopy are invited to participate in the present study.

You may qualify if:

  • Consecutive outpatients undergoing colonoscopy for one of the following indication:
  • FIT-based screening program
  • voluntary screening
  • post-polipectomy surveillance
  • gastrointestinal symptoms
  • family history of colorectal cancer.

You may not qualify if:

  • urgent colonoscopy
  • patients in which polyps could not be resected (e.g ongoing anticoagulation therapy)
  • patients with past colorectal cancer or polyposis syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gastroenterology Unit, Valduce Hospital

Como, 22100, Italy

Location

MeSH Terms

Conditions

Colonic Polyps

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Gastroenterology Unit

Study Record Dates

First Submitted

August 5, 2022

First Posted

August 8, 2022

Study Start

August 5, 2022

Primary Completion

November 5, 2022

Study Completion

November 5, 2022

Last Updated

March 26, 2024

Record last verified: 2024-03

Locations